Xeroderma pigmentosum[*]

Zusammenfassung

Im Rahmen einer Festveranstaltung zum 75. Geburtstag von Herrn Professor Dr. med. E. G. Jung fand im Universitätsklinikum Mannheim eine Vortragsreihe zur Würdigung des Jubilars statt. Herr Prof. Dr. Jung ist der Pionier der molekular-genetischen Xeroderma pigmentosum-Forschung in Deutschland. Der Vortrag Xeroderma pigmentosum stellte anhand von 3 ausgewählten Studienbeispielen die Bedeutung der molekular-genetischen Diagnostik von Xeroderma pigmentosum-Patienten für die Abschätzung des Hautkrebsrisikos in der allgemeinen Bevölkerung dar.

Abstract

To honor the 75th birthday of Professor Dr. med. E. G. Jung a symposium was held at the University Clinic Mannheim. Prof. Dr. E. G. Jung is the pioneer of molecular-genetic xeroderma pigmentosum research in Germany. The lecture xeroderma pigmentosum highlighted the impact of molecular-genetic testing of xeroderma pigmentosum patients for risk evaluation of skin cancerogenesis in the general population.

Literatur

• 1 Emmert S, Leibeling D, Runger T M. Syndromes with genetic instability: Model diseases for (skin) cancerogenesis.  JDDG. 2006;  4 721-733
• 2 Thoms K M, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes.  Exp Dermatol. 2007;  16 532-544
• 3 Petit C, Sancar A. Nucleotide excision repair: from E. coli to man.  Biochimie. 1999;  81 15-25
• 4 Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer.  J Mol Histol. 2006;  37 225-238
• 5 Emmert S, Wetzig T, Imoto K, Khan S G, Oh K S, Laspe P, Zachmann K, Simon J C, Kraemer K H. A Novel Complex Insertion/Deletion Mutation in the XPC DNA Repair Gene Leads to Skin Cancer in an Iraqi Family.  J Invest Dermatol. 2006;  126 2542-2544
• 6 Bootsma D, Kraemer K H, Cleaver J E, Hoeijmakers J H. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds). The Genetic Basis of Human Cancer. New York; McGraw-Hill 2002
• 7 Jung E G, Bohnert E, Fischer E. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.  Photodermatol. 1986;  3 125-132
• 8 Protic-Sabljic M, Kraemer K H. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells.  Proc Natl Acad Sci U S A. 1985;  82 6622-6626
• 9 Emmert S, Slor H, Busch D B, Batko S, Albert R B, Coleman D, Khan S G, Abu-Libdeh B, DiGiovanna J J, Cunningham B B, Lee M M, Crollick J, Inui H, Ueda T, Hedayati M, Grossman L, Shahlavi T, Cleaver J E, Kraemer K H. Relationship of Neurologic Degeneration to Genotype in Three Xeroderma Pigmentosum Group G Patients.  J Invest Dermatol. 2002;  118 972-982
• 10 Khan S G, Oh K S, Shahlavi T, Ueda T, Busch D B, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker C C, Di Giovanna J J, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer K H. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.  Carcinogenesis. 2006;  27 84-94
• 11 Blankenburg S, Konig I R, Moessner R, Laspe P, Thoms K M, Krueger U, Khan S G, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer K H, Emmert S. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.  Carcinogenesis. 2005;  26 1085-1090
• 12 Wei Q, Lee J E, Gershenwald J E, Ross M I, Mansfield P F, Strom S S, Wang L E, Guo Z, Qiao Y, Amos C I, Spitz M R, Duvic M. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.  J Natl Cancer Inst. 2003;  95 308-315
• 13 Khan S G, Muniz-Medina V, Shahlavi T, Baker C C, Inui H, Ueda T, Emmert S, Schneider T D, Kraemer K H. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.  Nucleic Acids Res. 2002;  30 3624-3631
• 14 Haenssle H A, Krueger U, Vente C, Thoms K M, Bertsch H P, Zutt M, Rosenberger A, Neumann C, Emmert S. Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma.  J Invest Dermatol. 2006;  126 980-985
• 15 Braun R P, Lemonnier E, Guillod J, Skaria A, Salomon D, Saurat J H. Two types of pattern modification detected on the follow-up of benign melanocytic skin lesions by digitized epiluminescence microscopy.  Melanoma Res. 1998;  8 431-437
• 16 Carli P, de Giorgi V, Chiarugi A, Nardini P, Weinstock M A, Crocetti E, Stante M, Giannotti B. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study.  J Am Acad Dermatol. 2004;  50 683-689
• 17 Robinson J K, Nickoloff B J. Digital epiluminescence microscopy monitoring of high-risk patients.  Arch Dermatol. 2004;  140 49-56
• 18 Schiffner R, Schiffner-Rohe J, Landthaler M, Stolz W. Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance.  Br J Dermatol. 2003;  149 79-86
• 19 Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions.  J Am Acad Dermatol. 1987;  17 571-583
• 20 Ascierto P A, Palmieri G, Celentano E, Parasole R, Caraco C, Daponte A, Chiofalo M G, Melucci M T, Mozzillo N, Satriano R A, Castello G. Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions. The Melanoma Cooperative Study.  Br J Dermatol. 2000;  142 893-898

1 Vortrag im Rahmen des Festsymposiums zu Ehren des 75. Geburtstages von Herrn Prof. Jung.